chr11-45934062-G-A
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 1P and 14B. PP2BP4_ModerateBP6_Very_StrongBS2
The NM_001352027.3(PHF21A):c.1952C>T(p.Thr651Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000402 in 1,613,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T651S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001352027.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PHF21A | NM_001352027.3 | c.1952C>T | p.Thr651Ile | missense_variant | 19/19 | ENST00000676320.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PHF21A | ENST00000676320.1 | c.1952C>T | p.Thr651Ile | missense_variant | 19/19 | NM_001352027.3 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000172 AC: 43AN: 249950Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135288
GnomAD4 exome AF: 0.000425 AC: 621AN: 1461626Hom.: 0 Cov.: 32 AF XY: 0.000413 AC XY: 300AN XY: 727116
GnomAD4 genome AF: 0.000177 AC: 27AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74346
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 10, 2024 | - - |
PHF21A-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 26, 2024 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at